-
Study aim
-
Determining the Effect of Intraperitoneal Dexamethasone Combined with Bupivacaine along with Lung Recruitment Maneuver Positioning on Pain, Nausea and Vomiting after Laparoscopic Cholecystectomy at Imam Khomeini Hospital, Sari, in 2025.
-
Design
-
A phase 3, double-blind clinical trial on 80 patients, with a control group and 3 intervention groups, 20 people per group. The random allocation sequence of patients to the study groups was generated using the block randomization method. For this purpose, 8-member blocks and the online software at https://www.sealedenvelope.com were used.
-
Settings and conduct
-
After performing the study interventions at Imam Khomeini Hospital in Sari, abdominal and shoulder pain using the VAS tool, and nausea and vomiting using the Emesis Score tool, will be measured by an evaluator at 2, 6, 12, 18, 24, and 48 hours.
-
Participants/Inclusion and exclusion criteria
-
Patients aged 18 to 60 years with an ASA physical status of I or II and a body mass index of less than 40 kg/m² who are candidates for elective laparoscopic cholecystectomy. Patients with a lack of informed consent, inability to perform the maneuver, or a history of abdominal or shoulder surgery are excluded from the study.
-
Intervention groups
-
The first group will only receive the pulmonary maneuver, which includes 5 manual breaths to reach an airway pressure of 40 cmH₂O and maintain it for 5 seconds in the supine position. The second group will be injected intraperitoneally with 40 cc of 0.25% bupivacaine along with 16 mg of dexamethasone, and the patient will be placed in the Trendelenburg position for 10 minutes. The third group will receive both interventions (first the drug, then the maneuver). The control group will undergo standard laparoscopic cholecystectomy without any intervention.
-
Main outcome variables
-
Abdominal Pain, Shoulder Pain, Nausea, and Vomiting Following Laparoscopic Cholecystectomy